News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Sanofi-Aventis (France) Gets Clearance To Market Plavix In Japan
January 25, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
PARIS (Reuters) - Sanofi-Aventis (SASY.PA: Quote, Profile, Research), the world's third-largest drugmaker, said on Tuesday it had won clearance from Japanese authorities to market its blood-thinner treatment product Plavix in Japan.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Postmarket research
Regulatory
Europe
Bristol Myers Squibb Company
Sanofi
MORE ON THIS TOPIC
Weight loss
Regeneron’s Weight Loss Partner Hansoh Delivers Much-Needed Phase 3 Win in China
March 9, 2026
·
2 min read
·
Annalee Armstrong
Breast cancer
Roche Breast Cancer Prospect Fails First-Line Test, Shares Fall
March 9, 2026
·
2 min read
·
Annalee Armstrong
Drug Development
Xenon To Seek Approval of First-in-Class Epilepsy Drug After Exceeding Phase 3 Expectations
March 9, 2026
·
3 min read
·
Heather McKenzie
Cancer
Ipsen Pulls Cancer Drug Amid Risk of Secondary Malignancies
March 9, 2026
·
2 min read
·
Tristan Manalac
